392 related articles for article (PubMed ID: 26081836)
1. Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer.
Chen CL; Chung T; Wu CC; Ng KF; Yu JS; Tsai CH; Chang YS; Liang Y; Tsui KH; Chen YT
Mol Cell Proteomics; 2015 Sep; 14(9):2466-78. PubMed ID: 26081836
[TBL] [Abstract][Full Text] [Related]
2. Identification and verification of transgelin-2 as a potential biomarker of tumor-derived lung-cancer endothelial cells by comparative proteomics.
Jin H; Cheng X; Pei Y; Fu J; Lyu Z; Peng H; Yao Q; Jiang Y; Luo L; Zhuo H
J Proteomics; 2016 Mar; 136():77-88. PubMed ID: 26721444
[TBL] [Abstract][Full Text] [Related]
3. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers.
Tomiyama E; Matsuzaki K; Fujita K; Shiromizu T; Narumi R; Jingushi K; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kato T; Hatano K; Kawashima A; Ujike T; Uemura M; Takao T; Adachi J; Tomonaga T; Nonomura N
Cancer Sci; 2021 May; 112(5):2033-2045. PubMed ID: 33721374
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Investigation toward the Indicative Proteins of Bladder Cancer in Urine: From Surveying Cell Secretomes to Verifying Urine Proteins.
Guo J; Ren Y; Hou G; Wen B; Xian F; Chen Z; Cui P; Xie Y; Zi J; Lin L; Wu S; Li Z; Wu L; Lou X; Liu S
J Proteome Res; 2016 Jul; 15(7):2164-77. PubMed ID: 27265680
[TBL] [Abstract][Full Text] [Related]
6. Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.
Chi LM; Lee CW; Chang KP; Hao SP; Lee HM; Liang Y; Hsueh C; Yu CJ; Lee IN; Chang YJ; Lee SY; Yeh YM; Chang YS; Chien KY; Yu JS
Mol Cell Proteomics; 2009 Jul; 8(7):1453-74. PubMed ID: 19297561
[TBL] [Abstract][Full Text] [Related]
7. Far from resolved: stromal cell-based iTRAQ research of muscle-invasive bladder cancer regarding heterogeneity.
Liu PF; Wang YH; Cao YW; Jiang HP; Yang XC; Wang XS; Niu HT
Oncol Rep; 2014 Oct; 32(4):1489-96. PubMed ID: 25050759
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology.
Lee H; Kim K; Woo J; Park J; Kim H; Lee KE; Kim H; Kim Y; Moon KC; Kim JY; Park IA; Shim BB; Moon JH; Han D; Ryu HS
Mol Cell Proteomics; 2018 Sep; 17(9):1788-1802. PubMed ID: 29950347
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery.
Xiao H; Langerman A; Zhang Y; Khalid O; Hu S; Cao CX; Lingen MW; Wong DTW
Oral Oncol; 2015 Nov; 51(11):1011-1019. PubMed ID: 26321370
[TBL] [Abstract][Full Text] [Related]
10. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
11. MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma.
Elsner M; Rauser S; Maier S; Schöne C; Balluff B; Meding S; Jung G; Nipp M; Sarioglu H; Maccarrone G; Aichler M; Feuchtinger A; Langer R; Jütting U; Feith M; Küster B; Ueffing M; Zitzelsberger H; Höfler H; Walch A
J Proteomics; 2012 Aug; 75(15):4693-704. PubMed ID: 22365974
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity research in muscle-invasive bladder cancer based on differential protein expression analysis.
Liu PF; Cao YW; Jiang HP; Wang YH; Yang XC; Wang XS; Niu HT
Med Oncol; 2014 Sep; 31(9):21. PubMed ID: 25085780
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
[TBL] [Abstract][Full Text] [Related]
14. Profilin 1 is a potential biomarker for bladder cancer aggressiveness.
Zoidakis J; Makridakis M; Zerefos PG; Bitsika V; Esteban S; Frantzi M; Stravodimos K; Anagnou NP; Roubelakis MG; Sanchez-Carbayo M; Vlahou A
Mol Cell Proteomics; 2012 Apr; 11(4):M111.009449. PubMed ID: 22159600
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
[TBL] [Abstract][Full Text] [Related]
16. Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.
Zhu J; Nie S; Wu J; Lubman DM
J Proteome Res; 2013 Jun; 12(6):2791-804. PubMed ID: 23679566
[TBL] [Abstract][Full Text] [Related]
17. Targeting amine- and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers.
Chen YT; Huang HC; Hsieh YJ; Fu SH; Li L; Chen CL; Chu LJ; Yu JS
J Food Drug Anal; 2019 Apr; 27(2):460-474. PubMed ID: 30987717
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics.
Chen CL; Lin TS; Tsai CH; Wu CC; Chung T; Chien KY; Wu M; Chang YS; Yu JS; Chen YT
J Proteomics; 2013 Jun; 85():28-43. PubMed ID: 23631828
[TBL] [Abstract][Full Text] [Related]
19. Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification.
Yang N; Feng S; Shedden K; Xie X; Liu Y; Rosser CJ; Lubman DM; Goodison S
Clin Cancer Res; 2011 May; 17(10):3349-59. PubMed ID: 21459797
[TBL] [Abstract][Full Text] [Related]
20. Large-Scale SRM Screen of Urothelial Bladder Cancer Candidate Biomarkers in Urine.
Duriez E; Masselon CD; Mesmin C; Court M; Demeure K; Allory Y; Malats N; Matondo M; Radvanyi F; Garin J; Domon B
J Proteome Res; 2017 Apr; 16(4):1617-1631. PubMed ID: 28287737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
